Evidence map›Paper›PMID 22618297›Full record

ArticleInternational journal of public health2013

Gender differences in healthy life years within the EU: an exploration of the "health-survival" paradox.

Herman Van Oyen, Wilma Nusselder, Carol Jagger, Petra Kolip, Emmanuelle Cambois, Jean-Marie Robine

Abstract read
In one paragraph

Article in International journal of public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [The gender paradox in health-impaired lifetime-end of a myth?]Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Herman Van OyenDirectorate of Public Health and Surveillance, Scientific Institute of Public Health, J. Wytsmanstraat 14, 1050 Brussels, Belgium. herman.vanoyen@wiv-isp.be
Wilma Nusselder
Carol Jagger
Petra Kolip
Emmanuelle Cambois
Jean-Marie Robine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluated the female-male health-survival paradox by estimating the contribution of women's mortality advantage versus women's disability disadvantage.

methodsDisability prevalence was measured from the 2006 Survey on Income and Living Conditions in 25 European countries. Disability prevalence was applied to life tables to estimate healthy life years (HLY) at age 15. Gender differences in HLY were split into two parts: that due to gender inequality in mortality and that due to gender inequality in disability. The relationship between women's mortality advantage or disability disadvantage and the level of population health between countries was analysed using random-effects meta-regression.

resultsWomen's mortality advantage contributes to more HLY in women; women's higher prevalence of disability reduces the difference in HLY. In populations with high life expectancy women's advantage in HLY was small or even a men's advantage was found. In populations with lower life expectancy, the hardship among men is already evident at young ages.

conclusionsThe results suggest that the health-survival paradox is a function of the level of population health, dependent on modifiable factors.

Indexed as

Life ExpectancyMortalityWomen's HealthAdolescentAdultCross-Sectional StudiesDisability EvaluationEuropeFemaleHealth StatusHealth SurveysHumansMaleMiddle AgedPersons with DisabilitiesPrevalence

Identifiers

PMID22618297
PMCPMC3557379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.